A636P testing in Ashkenazi Jews

Autor: Palmer Crystal, Offit Kenneth, G. guillem Jose, G. moore Harvey, Glogowski Emily, Nafa Khedoudja, Rob Finch, A. Ellis Nathan, J. Markowitz Arnold
Rok vydání: 2004
Předmět:
Zdroj: Familial Cancer. 3:223-227
ISSN: 1573-7292
1389-9600
DOI: 10.1007/s10689-004-0899-z
Popis: Hereditary nonpolyposis colorectal cancer (HNPCC) is an autosomal dominantly inherited colorectal cancer syndrome attributable to mutations in one of several DNA mismatch repair genes, most commonly MLH1 and MSH2 . In certain populations, founder mutations account for a substantial portion of HNPCC. In this report we summarize the literature and our personal experience testing for a specific founder mutation in the Ashkenazi Jewish population, MSH2*1906GC , also known as A636P. Although rare in the general population, the A636P mutation is detected in up to 7% of Ashkenazi Jewish patients with early age-of-onset colorectal cancer, and may account for up to one third of HNPCC in the Ashkenazi Jewish population. In addition, we summarize our initial experience with a prospective A636P testing protocol aimed at Ashkenazi Jewish patients at high or intermediate risk for harboring the A636P mutation.
Databáze: OpenAIRE